Aucun résultat
Zeev Rosberger has been continuously funded for research in psychosocial oncology studies that span the entire cancer trajectory – more recently population risk and prevention, but also through survivorship and recurrence phases.
Zeev Rosberger was (until 2017) the Chief of the Psychology Department at the Jewish General Hospital, providing exemplary clinical care to patients and their families. He also spearheaded the development of the Louise Granofsky-Psychosocial Oncology Program at the Segal Cancer Centre of the Jewish General Hospital. He participated on numerous provincial and national committees advocating for improvement of the emotional care for cancer patients and their families. He participated in the development of the National Distress Screening Guidelines (Canadian Partnership Against Cancer-CPAC), which were subsequently endorsed by multiple agencies (e.g, WHO, UICC, etc.) and implemented internationally.
From 2004-2006, he was President of the Canadian Association of Psychosocial Oncology. At the same time, he sat on the management committee of the Canadian Strategy for Cancer Control, a coalition of advocacy and professional groups who successfully lobbied the federal government to create CPAC.
Pr. Rosberger is currently vice-president of HPV Global Action, an NGO which provides educational resources about sexual health and is developing partnerships and programs nationally and internationally (in sub-Saharan Africa) in the prevention of Human Papillomavirus-related cancers.
Over a number of decades, Pr. Zeev Rosberger has led research programs in multiple areas of psychosocial oncology. His current research focus is on the prevention of Human Papillomavirus (HPV), a sexually transmitted infection, and HPV- related diseases (e.g., cervical cancer, penile cancer, genital warts, oropharyngeal cancer). His studies examine psychosocial correlates and predictors of Pap screening, HPV testing, and uptake of the HPV vaccine in several populations.
Rodin, D., Dare, A. J., Booker, R., Booth, C., Bryant, H., Ginsburg, O., Giuliani, M., Gospodarowicz, M., Gupta, S., Hammad, N., Rosberger, Z., Sutcliffe, S., & Earle, C. C. (2021). The Lancet Oncology, 22(9), 400–409. doi: 10.1016/S1470-2045(21)00374-0.
Steben, M., Norris, T., Rosberger, Z., & HPV Global Action (2020). Journal of obstetrics and gynaecology Canada, 42(10), 1195–1196. doi: 10.1016/j.jogc.2020.08.006.
Tatar O., Wade K., McBride E., Thompson E., Head K.J, Perez S., Shapiro G.K., Waller J., Zimet G., Rosberger Z. (2019, in press). Journal of Women’s Health. doi: 10.1089/jwh.2019.7678.
Tatar O., Shapiro G.K., Perez S., Wade K., Rosberger Z. (2019). Human Vaccines & Immunotherapeutics. doi: 10.1080/21645515.2019.1575711.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
